(Q35451154)

8 August 2017

title

Comparison of mouse bioassay and immunoprecipitation assay for botulinum toxin antibodies (English)

1 reference

8 August 2017

Hanna PA

1

1 reference

8 August 2017

Jankovic J

series ordinal

2

1 reference

8 August 2017

Vincent A

series ordinal

3

1 reference

8 August 2017

language of work or name

English

0 references

publication date

1 May 1999

1 reference

Journal of Neurology, Neurosurgery and Psychiatry

8 August 2017

published in

1 reference

8 August 2017

volume

66

1 reference

8 August 2017

issue

5

1 reference

8 August 2017

page(s)

612-616

1 reference

Further studies using higher doses of botulinum toxin type F for torticollis resistant to botulinum toxin type A

8 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736353

Botulinum neurotoxin serotype C: a novel effective botulinum toxin therapy in human.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736353

Monoclonal antibody-based immunoassay for type A Clostridium botulinum toxin is comparable to the mouse bioassay

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736353

Botulinum toxin therapy in hemifacial spasm: clinical and electrophysiologic studies

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736353

Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736353

Therapeutic uses of botulinum toxin

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736353

Therapeutic potential of botulinum toxin in neurological disorders

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736353

Enzyme-linked immunosorbent assay for detection of Clostridium botulinum toxin type A

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736353

Mouse bioassay versus Western blot assay for botulinum toxin antibodies: correlation with clinical response

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736353

A radioimmuno-precipitation assay for antibodies to botulinum A.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736353

Botulinum toxin type B: a double-blind, placebo-controlled, safety and efficacy study in cervical dystonia

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736353

Botulinum toxin treatment in patients with focal dystonia and hemifacial spasm. A multicenter study of the Italian Movement Disorder Group

26 September 2018

1 reference

12 December 2020

Botulinum antibodies in dystonic patients treated with type A botulinum toxin: frequency and significance

1 reference

12 December 2020

Serum antibody production to botulinum A toxin

1 reference

12 December 2020

Response and immunoresistance to botulinum toxin injections

1 reference

12 December 2020

Long-term effects of botulinum toxin injections in spasmodic dysphonia

1 reference

12 December 2020

Identifiers

DOI

10.1136/JNNP.66.5.612

1 reference

8 August 2017

1 reference

8 August 2017

1 reference